Skip to content
10-Q

Quarterly Report

Intellicell Biosciences, Inc.

0001013762-14-001208

← back to feed
Filed
Oct 10, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q2 2014 · Jun 30, 2014 23.78B sh
Shares Diluted Q2 2014 · Jun 30, 2014 1.83B sh
Shares Outstanding Q2 2014 · Jun 30, 2014 3.66B sh
Capex Q2 2014 · Jun 30, 2014 $30.56K
Operating Cash Flow Q2 2014 · Jun 30, 2014 −$2.17M
Stockholders Equity Q2 2014 · Jun 30, 2014 −$12.3M
Stockholders Equity Q2 2014 · Dec 31, 2013 −$12.28M
Current Liabilities Q2 2014 · Jun 30, 2014 $15.64M
Current Liabilities Q2 2014 · Dec 31, 2013 $15.5M
Total Liabilities Q2 2014 · Jun 30, 2014 $15.64M
Total Liabilities Q2 2014 · Dec 31, 2013 $15.5M
Current Assets Q2 2014 · Jun 30, 2014 $321.4K
Current Assets Q2 2014 · Dec 31, 2013 $9K
Total Assets Q2 2014 · Jun 30, 2014 $3.34M
Total Assets Q2 2014 · Dec 31, 2013 $3.21M
Eps Diluted Q2 2014 · Jun 30, 2014 $0.00
Eps Diluted Q2 2014 · Jun 30, 2014 $0.00
Eps Basic Q2 2014 · Jun 30, 2014 $0.00
Eps Basic Q2 2014 · Jun 30, 2014 $0.00
Sga Expense Q2 2014 · Jun 30, 2014 $811.61K
Sga Expense Q2 2014 · Jun 30, 2014 $1.19M
Rd Expense Q2 2014 · Jun 30, 2014 $90.5K
Rd Expense Q2 2014 · Jun 30, 2014 $270.5K
Net Income Q2 2014 · Jun 30, 2014 $2.71M
Net Income Q2 2014 · Jun 30, 2014 −$7.53M
Operating Income Q2 2014 · Jun 30, 2014 −$1.24M
Operating Income Q2 2014 · Jun 30, 2014 −$2.82M
Gross Profit Q2 2014 · Jun 30, 2014 $29.57K
Gross Profit Q2 2014 · Jun 30, 2014 $57.46K
Gross Profit Q2 2014 · Jun 30, 2013 $0
Gross Profit Q2 2014 · Jun 30, 2013 $0
Cost Of Revenue Q2 2014 · Jun 30, 2014 $2.93K
Cost Of Revenue Q2 2014 · Jun 30, 2014 $7.55K
Cost Of Revenue Q2 2014 · Jun 30, 2013 $0
Cost Of Revenue Q2 2014 · Jun 30, 2013 $0
Revenue Q2 2014 · Jun 30, 2014 $32.5K
Revenue Q2 2014 · Jun 30, 2014 $65K
Revenue Q2 2014 · Jun 30, 2013 $0
Revenue Q2 2014 · Jun 30, 2013 $0
Cash And Equivalents Q2 2014 · Dec 31, 2013 $0
Cash And Equivalents Q2 2014 · Jun 30, 2013 $106
Cash And Equivalents Q2 2014 · Dec 31, 2012 $10.16K